Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Save for later
Funded Studies
Donate Now
Funding Save for later

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (208${count})
  • Fall 2021 RFP: Outcome Measures, 2022
    Development of Standardized Measurements for Monitoring the Progression of Parkinson’s Disease via MRI

    Study Rationale: One of the difficulties in research towards new treatments in Parkinson’s disease (PD) is the diversity of disease presentations and the lack of tools to measure the effect of a...
    Researchers:

    Kathleen Poston, MD, MS | Annemie Ribeens, PhD

    Details
  • Biomarkers to Support Therapeutic Trials Program, 2023
    Using Neurophysiology as a Stratification Tool for Synucleinopathy

    Study Rationale: Although numerous disease-modifying drugs are being developed for Parkinson’s disease (PD), the current methods used to identify people suitable for clinical trials are costly...
    Researchers:

    Anat Mirelman, PhD

    Details
  • Biosample and Tissue Resource, 2013
    Relationship of Vitamin B12 Status and Parkinson's Disease

    Objective/Rationale:             
    Vitamin B12 deficiency can cause a number of neurological symptoms, including instability, neuropathy (which may cause numbness and tingling) and cognitive defects...
    Researchers:

    Ralph Green, MD, PhD | Chadwick Wilson Christine, MD

    Details
  • MJFF Research Grant, 2011
    fMRI of First Degree Relatives of LRRK2 Positive PD Patients

    Objective/Rationale:

    First, to study the effect of the presence of the LRRK2 G2019S mutation on brain activation patterns in Parkinson’s disease (PD) patients who recently converted into a diseased...
    Researchers:

    Nir Giladi, MD

    Details
  • Rapid Response Innovation Awards, 2014
    Effect of Dietary Ketosis On Alpha-Synuclein Accumulation

    Study Rationale:
    A key feature of Parkinson’s disease is abnormal accumulation of the protein alpha-synuclein. Production of organic compounds called ketones is a normal metabolic process that occurs...
    Researchers:

    Sheila Marie Fleming, PhD

    Details
  • Accelerating Biological Understanding and Therapeutic Translation for PD-Biology, 2025
    GBA1 Consortium: Joint Analysis to Inform Clinical Trials

    Study Rationale: Variants in the GB1A gene represent the most important genetic risk factor for Parkinson’s disease (PD) across the globe. However, different GBA1 variants are associated with varied...
    Researchers:

    Kathrin Brockmann, MD

    Details
Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.